Cargando…
Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma
PURPOSE: Over 90% of uveal melanomas harbor pathogenic variants of the GNAQ or GNA11 genes that activate survival pathways. As previous studies found that Ras-mutated cell lines were vulnerable to a combination of survival pathway inhibitors and the histone-deacetylase inhibitor romidepsin, we inves...
Autores principales: | Patel, Ruchi P., Thomas, Joanna R., Curt, Katherine M., Fitzsimmons, Christina M., Batista, Pedro J., Bates, Susan E., Gottesman, Michael M., Robey, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458781/ https://www.ncbi.nlm.nih.gov/pubmed/34533562 http://dx.doi.org/10.1167/iovs.62.12.16 |
Ejemplares similares
-
Prognostic Factors Five Years After Enucleation for Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2020) -
Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021) -
ICG-001 Exerts Potent Anticancer Activity Against Uveal Melanoma Cells
por: Kaochar, Salma, et al.
Publicado: (2018) -
PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma
por: Vaquero-Garcia, Jorge, et al.
Publicado: (2017) -
Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma
por: Glinkina, Kseniya, et al.
Publicado: (2022)